Transcription of The EULAR points to consider for use of antirheumatic ...
{{id}} {{{paragraph}}}
Example: bankruptcy
The EULAR points to consider for use of antirheumatic ...
The EULAR points to consider for use ofantirheumatic drugs before pregnancy , and duringpregnancy and lactationCarina G testam Skorpen,1,2,3 Maria Hoeltzenbein,4 Angela Tincani,5 Rebecca Fischer-Betz,6 Elisabeth Elefant,7 Christina Chambers,8 Jos da Silva,9 Catherine Nelson-Piercy,10 Irene Cetin,11 Nathalie Costedoat-Chalumeau,12,13 Radboud Dolhain,14 Frauke F rger,15 Munther Khamashta,16 Guillermo Ruiz-Irastorza,17 Angela Zink,18 Jiri Vencovsky,19 Maurizio Cutolo,20 Nele Caeyers,21 Claudia Zumb hl,22 Monika stensen1,2 Handling editorTore K Kvien Additional material ispublished online only. To viewplease visit the journal online( ).For numbered affiliations seeend of toProfessor Monika stensen,National Service for Pregnancyand Rheumatic Diseases,Department of Rheumatology,Trondheim University Hospital,Trondheim 7006, 30 October 2015 Revised 21 December 2015 Accepted 22 January 2016To cite:G testamSkorpen C, Hoeltzenbein M,Tincani A,et RheumDisPublished Online First:[please includeDay MonthYear] European League Against Rheumatism ( EULAR ) taskforce was established to define points to consider on useof antirheumatic drugs
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation Carina Götestam Skorpen,1,2,3 Maria Hoeltzenbein,4 Angela Tincani,5 Rebecca Fischer-Betz,6 Elisabeth Elefant,7 Christina Chambers,8 Josè da Silva,9 Catherine Nelson-Piercy,10 Irene Cetin,11 Nathalie Costedoat-Chalumeau,12,13 Radboud Dolhain,14 Frauke Förger,15 Munther …
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: